Purpose: Deep vein thrombosis (DVT) is a preventable cause of morbidity and mortality in patients who are hospitalized. An important part of the mechanism of DVT prophylaxis with intermittent pneumatic compression (IPC) is reduced venous stasis with increased velocity of venous return. The conventional methods of IPC use low pressure and slow inflation of the air bladder on the leg to augment venous return. Recently, compression devices have been designed that produce high pressure and rapid inflation of air cuffs on the plantar plexus of the foot and the calf. The purpose of this study is to evaluate the venous velocity response to high-pressure, rapid-inflation compression devices versus standard, low-pressure, slow-inflation compression devices in healthy volunteers and patients with severe postthrombotic venous disease. Method: Twenty-two lower extremities from healthy volunteers and 11 lower extremities from patients with class 4 to class 6 post-thrombotic chronic venous insufficiency were studied. With duplex ultrasound scanning (ATL-Ultramark 9, Advanced Tech Laboratory, Bothell, Wash), acute DVT was excluded before subject evaluation. Venous velocities were monitored after the application of each of five IPC devices, with all the patients in the supine position. Three high-pressure, rapid-compression devices and two standard, low-pressure, slow-inflation compression devices were applied in a random sequence. Maximal venous velocities were obtained at the common femoral vein and the popliteal vein for all the devices and were recorded as the mean peak velocity of three compression cycles and compared with baseline velocities. Results: The baseline venous velocities were higher in the femoral veins than in the popliteal veins in both the volunteers and the post-thrombotic subjects. Standard and high-pressure, rapid-inflation compression significantly increased the popliteal and femoral vein velocities in healthy and post-thrombotic subjects. High-pressure, rapid-inflation compression produced significantly higher maximal venous velocities in the popliteal and femoral veins in both healthy volunteers and patients who were post-thrombotic as compared with standard compression. Compared with the healthy volunteers, the patients who were post-thrombotic had a significantly attenuated velocity response at both the popliteal and the femoral vein levels. Conclusion: High-pressure, rapid-inflation pneumatic compression increases popliteal and femoral vein velocity as compared with standard, low-pressure, slow-inflation pneumatic compression. Patients with post-thrombotic venous disease have a compromised hemodynamic response to all IPC devices. However, an increased velocity response to the high-pressure, rapid-inflation compression device is preserved. High-pressure, rapid-inflation pneumatic compression may offer additional protection from thrombotic complications on the basis of an improved hemodynamic response, both in healthy volunteers and in patients who were post-thrombotic. (J Vasc Surg 1999;29:593-9.) 593
Deep vein thrombosis (DVT) is a preventable cause of morbidity and mortality in patients who are hospitalized and remains a major problem in the postoperative period. Venous stasis, endothelial injury, and hypercoagulability are important contributors to the development of deep venous thrombosis as proposed in 1856 by Virchow . 1 Intermittent pneumatic compression (IPC) is a safe and effective method used to prevent the development of deep vein thrombosis [2] [3] [4] and may affect two of the three factors proposed by Virchow. 1 The mechanism of IPC is thought to be twofold: a fluid mechanical effect of IPC expels venous blood from the lower extremities, which increases the velocity of venous return and reduces stasis. Venous stasis can be described as decreased venous return affected by valvular abnormalities, venous obstruction, or possible endothelial injury. It has been shown radiographically and isotopically that venous stasis occurs especially in the lower leg. [5] [6] [7] IPC also produces a hematologic alteration, which reduces the hypercoagulable state with the enhancement of fibrinolytic activity [8] [9] [10] [11] and tissue factor pathway inhibitor. 12 In recent years, IPC has witnessed an increased popularity for DVT prophylaxis. A metaanalysis of more than 70 published trials of DVT prophylaxis in patients for surgery has shown that the use of mechanical prophylaxis significantly reduces the rates of DVT and fatal pulmonary embolism. 4 The conventional methods of IPC use low-pressure, slow-inflation compression with sequential or single chambers attached to the calf or calf and thigh to augment venous return. Recently, compression devices have been designed that produce rapid compression of the plantar plexus of the foot and calf to augment venous return.
Patients with post-thrombotic venous disease are known to be at an increased risk for the development of postoperative thromboembolic complications. 2 It has been observed that patients with postthrombotic venous disease have an intrinsic alteration of hemostatic balance and fail to show the same level of fibrinolytic enhancement with compression as do healthy volunteers. 11 Chronic obstruction and decreased compliance potentially can alter the hemodynamic response to compression, which further contributes to the risk of recurrent DVT.
The purpose of this study was the evaluation of whether there is a hemodynamic difference with high-pressure, rapid-inflation compression devices as compared with low-pressure, slow-inflation com-pression devices in healthy volunteers and patients with post-thrombotic disease.
METHODS
Thirty-three limbs of 22 subjects were studied with five different IPC devices. The subjects were categorized as healthy volunteers (n = 11, 22 extremities) or patients with class 4 to class 6 postthrombotic venous disease (n = 11, 11 extremities). 13 These classes of venous disease included patients with swollen, pigmented limbs (grade 4), limbs with venous ulcer (grade 5), and limbs with healed venous ulcers (grade 6). The average age was 42.5 years for the healthy volunteers and 48 years for the patients who were post-thrombotic. The healthy volunteers had no history or physical findings of venous or arterial disease. Routine venous duplex scan examinations with a 5-MHz probe (ATL-Ultramark 9, Advanced Tech Laboratory, Bothell, Wash) were performed to exclude the presence of asymptomatic DVT or evidence of previously undetected chronic venous disease. This technique has been described previously, and a 99% sensitivity rate for the detection of proximal DVT has been achieved in our vascular laboratory. 14 The patients who were post-thrombotic had a history of objectively documented proximal DVT that was treated with long-term anticoagulation therapy. All of these patients had venous duplex scan evidence of recanalization and thickening of the vein walls.
This study protocol was reviewed and approved by the institutional review board of Temple University Health Sciences Center, and each subject signed an informed consent. Standard compression was evaluated with two calf-length IPC devices: a calf-length sequential compression device (SCD, Kendall Healthcare Products Company, Mansfield, Mass) and a calf-length single-chamber compression device (DVT 10 Flowtron, Huntleigh Healthcare, Manalapan, NJ). High-pressure, rapid-inflation pneumatic compression was evaluated with three different devices: a foot pump (Plexipulse, NuTech, San Antonio Tex), a foot and calf pump (Plexipulse, NuTech), and the Art-Assist foot and calf pump (ACI Medical Corporation, San Marcos, Calif). The compression devices were applied in random sequence according to a table of random numbers. A comparision of the peak pressure, inflation times, and compression cycles of the devices used is listed in Table I .
The subjects were studied in the Clinical Research Center of Temple University Hospital.
Each subject was placed in the supine position for a minimum of 5 minutes before the application of the first compression device, and baseline venous velocities were recorded in centimeters per second. The selected compression device was applied and functioned for 5 minutes to achieve hemodynamic equilibrium. Maximal venous velocities were obtained from the common femoral vein cephalad to the saphenofemoral junction and from the mid popliteal vein for all the devices and recorded as the mean peak velocity of three compression cycles. The angle of insonation of the ultrasound scan beam with the vein was 60 degrees. Between the compression units, the subjects were placed transiently in a reverse Trendelenburg position to ensure the complete filling of the lower extremity veins. The subjects were returned to the supine position, and the next compression was begun after the venous velocities had returned to baseline.
In a preliminary evaluation, the extended effect of external pneumatic compression on venous hemodynamics was studied. The venous velocity response was monitored in subjects with compression garments in place for a period of 2 hours to determine the velocity profile over time with compression. Maximal velocities generated with compression reached equilibrium after 1 to 2 minutes and remained relatively constant. Therefore, a 5-minute compression time was chosen as representative of the velocity response expected in patients with prolonged compression. The reverse Trendelenburg position was used to fill the venous system between each device to ensure that there was no venous volume bias at the outset of compression against compression units used subsequent to the first.
Maximal velocities were calculated and recorded for each study subject. The effect of compression in healthy limbs and diseased limbs were analyzed separately. Comparisons between healthy subjects and patients who were post-thrombotic were performed with a two-sample t test and within patient or volunteer groups with a paired t test. A similar analysis was performed that compared standard compression and rapid inflation devices. A pairwise comparison was performed for all the compression devices used.
RESULTS
The baseline velocities were higher in the femoral vein than in the popliteal vein in both the volunteers and the post-thrombotic subjects. Each compression unit increased the velocity in the femoral and popliteal veins in each subject. However, a greater relative velocity response occurred in the popliteal veins. High-pressure, rapid-inflation compression produced uniformly higher velocities than did standard compression at both the popliteal and the femoral vein levels. However, patients who were postthrombotic had a significantly attenuated velocity response at both levels with all the compression units (Table I) .
The relative velocity augmentation with compression is listed in Table II , which compares standard and high-pressure compression in healthy volunteers and patients who were post-thrombotic. These data show the relative increase in maximal venous velocity with high-pressure, rapid-inflation compression in all the subjects and the relatively attenuated velocity response in patients who were post-thrombotic. Although there is an attenuated velocity response in patients who were post-thrombotic to all the compression devices, relatively higher maximal velocities are observed with the highpressure, rapid-inflation compression devices (Tables  III and IV) .
A pair-wise comparison of the maximal velocities achieved with the five compression units showed a significantly higher maximal venous velocity from each high-pressure compression unit as compared with each standard compression unit (Table V) . However, there were no differences in maximal venous velocities between the high-pressure compression units or between the low-pressure, slowinflation units.
DISCUSSION
The important findings of this study are that there is a significantly higher maximal velocity response to high-pressure, rapid-inflation intermittent pneumatic compression and that individuals with objectively confirmed post-thrombotic deep venous disease have a compromised response to IPC.
It is not yet known that high-pressure, rapidinflation compression translates to clinical superiority, namely decreased venous thrombosis. However, a number of observations would lead one to hypothesize that this is true. It is intuitive that veins with accelerated velocities are less likely to thrombose than are veins with slower velocities. Clinical studies have confirmed that high-pressure, rapid-inflation compression is effective in reducing the occurrence of DVT in surgical patients who are at a high risk. 4 Although acceleration of a static volume of blood in the venous system appears to be advantageous, it may not be the only hemodynamic benefit. Similar high-pressure compression units have been shown to increase lower extremity arterial perfusion, which increases blood flow through the popliteal artery and increases foot skin perfusion. 15 It follows that increasing arterial inflow would provide an additional volume of blood in the venous system. Therefore, a larger volume of blood would be compressed with the high-pressure, rapid-inflation compression units and returned at higher maximal velocities. The subjects in this study underwent evaluation in the supine position to simulate the hemodynamics expected with routine patient care, not the position that would maximize the venous velocity response to compression. Because the reverse Trendelenburg position appears to improve the hemodynamics of compression (maximal velocity response), it may be prudent for patients to be placed in the reverse Trendelenburg position to take advantage of the maximal acceleration of venous return 16 and the augmentation of arterial inflow. 15 Unfortunately, we have found that nursing personnel have difficulty maintaining patients in the reverse Trendelenburg position for any extended period of time.
High-pressure, rapid-inflation may offer an incremental hematologic advantage. In a prior study, high-pressure, rapid-inflation compression with a foot compression device was found to increase endogenous fibrinolytic activity 11 and to increase tissue factor pathway inhibitor, which correlated with reduction of factor VIIa. 12 Although there was no difference between a high-pressure, rapid-inflation compression foot device and a standard calf-length or long-leg compression device, the observation was compelling that high-pressure, rapid-inflation compression of a small volume of tissue (foot) produced a similar hematalogic response to standard long-leg (calf and thigh) compression. Unfortunately, highpressure, rapid-inflation foot and calf compression was not available for evaluation during the prior study.
Although the mechanism for stimulating the hematologic alteration is not known, it is reasonable to postulate that increased shear stress on the vessel wall is important. Shear stresses that act on the endothelium arise from the radial velocity gradient characteristic of blood flow through a vessel, with slow flow (no flow) at the wall of the vessel and layers of increasing velocity that reach maximal velocity in center stream. There is increasing evidence that the size of the blood vessels and the vascular tone are dependent on the local level of shear stress and that endothelial cells mediate the response of vessels to changes in flow conditions. [17] [18] [19] [20] Most of the work in this area has been performed with cultured endothelial cells. However, there appears to be a consistency of observations with cell culture studies and clinical studies in humans. Although a higher maximal venous velocity and more rapid acceleration (shear) of venous return has strong theoretical and experimental evidence that supports its benefit, there is no direct clinical evaluation that supports a "patient outcome" advantage. Some might suggest that the lower but sustained velocity increase with low-pressure, slow-inflation compression devices is more beneficial than a transiently higher maximal velocity. This seems to be an important question. The clincal answer will necessitate a prospective trial with a large sample size.
Increased shear stress on endothelial cells has been found to increase the production of prostacyclin, 21 endothelial-derived relaxing factor (nitric oxide), [22] [23] [24] platelet-derived growth factor, 25 and tissue-type plasminogen activator. 26 On the other hand, an increase in shear stress reduces the production of interleukin-6 27 and alters pinocytosis 28 and transendothelial permeability. 29 These cell culture studies support the concept that physical measures that increase velocity (shear) are beneficial and that many and varied physiologic responses may be operative in addition to potentiation of fibrinolytic activity and alteration of the tissue factor pathway.
The patients in the study who were post-thrombotic had objectively documented residual disease in their deep veins, documented with recanalization or thickened walls on duplex scan imaging. They had a significantly compromised response to all the compression units. However, high-pressure, rapid-inflation compression generated higher maximal velocities than did standard compression. In a study that evaluated the fibrinolytic effects of IPC, the patients who were post-thrombotic were found to have lower baseline endogenous fibrinolytic activity than did the healthy subjects. It appears that there may be a correlation of the hemodynamic response with the hematologic response to IPC in similarly selected patients, which would explain why these patients are at a considerably higher risk of future venous thromboembolic events. Although high-pressure, rapidinflation compression shows improvement as compared with standard compression, it may not be enough to protect these patients at high risk from DVT. We would favor the combination of pharmacologic and mechanical prophylaxis to offer maximal protection for patients with post-thrombotic venous disease. The capability to stimulate accelerated venous return may be affected by the intrinsic properties of the veins, most notably obstruction and diminished compliance resulting from their thrombotic event. The elasticity of the venous system changes with age and post-thrombotic disease. 30 Salvian and Baker 31 evaluated the effects of pneumatic compression on post-thrombotic limbs and found no difference when compared with the healthy subjects. Their selection of patients who were post-thrombotic differed from ours in that their patients had patent venous systems with no evidence of obstruction. Our patients had severe clinical disease and evidence of obstruction shown by recanalization and thickened vein walls.
Unfortunately, there is no good method to noninvasively quantitate the degree of physiologic obstruction in the post-thrombotic venous system. We know that a large cross-sectional area of the vein lumen can be obliterated yet preserve "normal" maximal venous outflow at rest. 32 It is apparent that the degree of physiologic obstruction to venous return in patients who were post-thrombotic is frequently underestimated. Although venous duplex scan findings of recanalization and thickened vein walls are not physiologic nor quantitative, the findings suggest that obstruction of the venous system persists in the subjects studied and offers a potential explanation for the different velocity response in these patients who were post-thrombotic.
Ricci et al 33 studied the hemodynamic effects of high-pressure, rapid-inflation compression devices as compared with standard IPC. Their observations were similar to ours in terms of the augmentation of peak velocity in the popliteal vein with the highpressure, rapid-inflation devices. It is not clear why their observation of the femoral vein velocities were inconsistent with ours. They found a longer sustained venous flow pattern and a slower return to baseline velocity with standard calf IPC. This would be expected because the inflation time is longer as compared with the high-pressure devices studied.
The observations that high-pressure, rapid-inflation pneumatic compression shows higher maximal venous velocities and that patients who are postthrombotic have a compromised response to compression have important implications for clinical care and future studies. When deciding on methods of DVT prophylaxis, consideration should be given to stratifying patients according to the status of their deep venous system. Future studies in this area should take these issues into consideration and should include high-pressure, rapid-inflation compression as part of the protocol.
